A mother called our office last spring about her son, who was 24 and "not an alcoholic, just a weekend guy." He drank five or six beers on Fridays and Saturdays, held a good job, ran on weekdays, and had never had a hangover bad enough to miss work. She wanted to know whether there was anything to worry about yet, or whether the damage people talk about was decades away. A paper published this week from Brown University gives me a more precise answer than I had for her at the time, and the answer is that young men drinking at that level, on average, already show measurable differences in their blood.
What the Brown study measured
Mollie Monnig and colleagues at Brown University's Center for Alcohol and Addiction Studies published the study on September 7, 2026, in Alcohol: Clinical and Experimental Research. It used plasma from a randomized, placebo-controlled alcohol administration trial in 32 healthy adults with an average age of 25. Fifteen were light drinkers, averaging two drinks per week. Seventeen were heavy drinkers by NIAAA criteria, averaging about nine drinks per week and nearly six drinks per heavy-drinking occasion, and 13 of the 17 were binge drinking at least once a week. What matters most for the mother's question is how short their histories were. Heavy drinking had started around age 20 and had lasted, on average, less than two years. Only 4 of the 17 met criteria for mild alcohol use disorder. Nobody had a diagnosed chronic disease, and nobody was taking medication for one.
Participants were scheduled for three lab visits, at least three days apart, and most completed all three. On each visit they drank either a placebo, a low dose of alcohol (0.35 grams per kilogram, which produced a peak breath alcohol of about 0.034%), or a moderate dose (0.60 grams per kilogram, peaking around 0.063%). The order was randomized. Blood was drawn before the drink and every hour for four hours afterward. The researchers then measured ten proteins chosen ahead of time because each one sits on a known pathway to chronic disease: adiponectin and lipocalin-2 for metabolism, angiogenin, D-dimer, ICAM-1, and sRAGE for the lining of blood vessels, two matrix metalloproteinases for tissue remodeling, high-sensitivity C-reactive protein for inflammation, and TREM2 for immune signaling of the kind that microglia perform in the brain.
Five markers were already elevated
Across all three sessions and every time point, the heavy drinkers had higher circulating levels of five of the ten proteins than the light drinkers. Angiogenin was higher (p < 0.001), and so were ICAM-1 (p = 0.003), adiponectin (p = 0.034), lipocalin-2 (p = 0.027), and sRAGE (p = 0.047). Angiogenin and ICAM-1 are markers of an activated, stressed blood vessel lining, and elevated levels have been associated with heart disease and cerebrovascular disease. Lipocalin-2 tracks metabolic strain and low-grade inflammation. sRAGE is a circulating decoy receptor that mops up advanced glycation end products and amyloid-beta, and both high and depleted levels have been observed in diabetes, atherosclerosis, and other chronic inflammatory conditions.
The two groups did not differ in age, sex, race, education, or smoking status, and the authors ran sensitivity analyses on race and smoking that did not change the results. They are careful to say that these group differences are associations, not proof that the drinking caused them, because you cannot randomize a person to two years of heavy drinking. Still, in young, healthy, demographically matched adults, the drinking is the most economical explanation. The ones drinking heavily for less than two years already showed what the authors describe as early engagement of the vascular and metabolic pathways that lead to chronic disease.
What one drinking session does in four hours
The acute results were more subtle, and I think they are the more interesting part clinically. Under the moderate dose, sRAGE dipped in the first hour, as it did under placebo, but then rose again at hours two and three (p = 0.002 and p = 0.014). It did not do that under placebo or under the low dose. The authors suggest the rise may be a compensatory response, the body deploying its decoy receptor to buffer an increase in oxidative stress and inflammatory ligands after a drink that produced a breath alcohol of only 0.063%, which is below the 0.08% legal driving limit in every state. In my clinical judgment a single episode like that is unlikely to do lasting harm on its own. The authors' hypothesis is that repeated increases, several times a week for years, could dysregulate the AGE-RAGE signaling axis over time, and they note that this is consistent with the higher sRAGE they observed in heavy drinkers.
C-reactive protein was lower under the low dose than under placebo, and the authors caution against reading much into that, since CRP is made in the liver and moves too slowly for a four-hour change to reflect real inflammation. Three other proteins rose and fell from late morning into the afternoon no matter what was in the cup, a reminder that much of what uncontrolled studies report as an "effect" is simply the body's daily rhythm.
Why this fits what we already knew about the brain
This is the second paper from the same 32 people. In 2025, the same group reported in the same journal that heavy drinkers had 43% higher levels of sCD163, a marker of macrophage activation, and that their inflammatory cytokines moved differently after alcohol than the light drinkers' did. The heavy drinkers even showed what looked like selective immune suppression under placebo, when they expected alcohol but received none, which suggests the immune system itself had learned to anticipate the drink. Taken together, the two papers describe a young body whose vascular, metabolic, and immune systems appear to be running at a different set-point, one the authors call allostatic, in step with a habit that, by the trial's own screening, most of them were not seeking help for.
I have written before about the autopsy data showing that moderate drinking leaves measurable damage in the brain, and about how brain recovery takes closer to 18 months than 28 days. The Brown paper itself stops at the blood. The authors are explicit that plasma markers may not reflect what is happening inside the brain, and their one microglia-related marker, TREM2, did not move at all. But the endothelium and the inflammatory signaling these markers track are shared with the brain, and prior work the authors cite has linked heavy drinking to elevated RAGE expression in brain tissue. My clinical reading is that the blood vessel lining ICAM-1 and angiogenin report on is the same lining that feeds the hippocampus and the prefrontal cortex, and that the inflammatory tone lipocalin-2 and sRAGE reflect tends to shape how microglia treat neurons. Alcohol changes the environment every organ lives in, and the brain is one of those organs.
What this means for you or someone you love
If you are the parent of a weekend drinker in his twenties, this study is the evidence that the timeline is shorter than most families assume. It does not test reversibility, and the authors call for longitudinal studies to learn whether these shifts consolidate into lasting dysregulation. What I can say from three decades of practice is that early signals in a healthy 25-year-old are the kind of thing that tends to improve when the exposure stops, and that is a reason to act now rather than a reason to wait. The authors also note that sRAGE was remarkably stable within each person across the three visits, which is the kind of stability you would want in a marker before anyone tried to follow it clinically.
That is the approach we take in Rescue From Rehab. Rather than waiting for a liver panel or a cardiac event to declare that alcohol has done harm, we look for the early inflammatory and metabolic signals that standard labs can capture, treat the brain's recovery as a biological process with a timeline, and track whether the numbers move. A young person who learns that his blood already reflects his drinking is being given information he can act on, in a body that is still very good at healing.
For anyone further along, with a longer history and perhaps a diagnosis, the same logic applies with more urgency. These biomarkers can be measured, and measuring them is the first step toward changing them. Willpower and character were never the right frame for this problem. Biology is the right frame, and biology can be treated.
Illustration created with AI image tools.
This article was drafted with the assistance of AI writing tools, then reviewed, edited, and approved by Dr. Drew W. Edwards, Ed.D., who holds full editorial responsibility for its content.
References
- Monnig, M. A., Clark, S. E., & Monti, P. M. (2026). Effects of acute low- and moderate-dose alcohol on chronic disease-related biomarkers in healthy light and heavy drinkers. Alcohol: Clinical and Experimental Research, 50(9), e70362. https://doi.org/10.1111/acer.70362
- Monnig, M. A., Lamb, P. S., Clark, S. E., & Monti, P. M. (2025). Acute changes in immune biomarkers under low- and moderate-dose alcohol in light and heavy drinkers: A randomized, placebo-controlled trial. Alcohol: Clinical and Experimental Research, 49(8), 1644-1658. https://doi.org/10.1111/acer.70106
- ClinicalTrials.gov. Alcohol and Immune Response (Immune Activation and Neurodegeneration in HIV Infection and Heavy Drinking), NCT03483389 (registered March 30, 2018). https://clinicaltrials.gov/study/NCT03483389